Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma-Reference-Cited by-同舟云学术

Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma

Published:2021-10 Issue:21 Volume:10 Page:7585-7592
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Bastos‐Oreiro Mariana¹²³⁴^ORCID,Ortiz Javier¹,Pradillo Virginia¹,Salas Eduardo⁵^ORCID,Marínez‐Laperche Carolina¹²,Muñoz Andrés⁶,Buño Ismael¹²^ORCID,Diéz‐Martin José Luis¹²,Soria Jose Manuel⁷,Pascual Izquierdo Cristina¹²

Affiliation:

1. Hematology Department Hospital General Universitario Gregorio Marañon Madrid Spain

2. Gregorio Marañón Health Research Institute Madrid Spain

3. Genomics Unit, Hospital General Universitario. Gregorio Marañón Madrid Spain

4. Cell Biology Department School of Medicine, Universidad Complutense de Madrid Madrid Spain

5. Gendiag, S.L. Scientific Department Barcelona Spain

6. Oncology Department Hospital General Universitario Gregorio Marañón Madrid Spain

7. Hospital Universitario de la Santa Creu I Santa Pau Barcelona Spain

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4280

Reference33 articles.

1. Venous thromboembolism in the hematologic malignancies

2. Venous thromboembolism incidence in hematologic malignancies

3. Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment

4. Lymphoma and venous thromboembolism: influence on mortality

5. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External validation of the Khorana score for the prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis;International Journal of Nursing Studies;2024-11

2. Cancer-associated thrombosis: the role of inherited thrombophilia;Blood Coagulation & Fibrinolysis;2024-07-26

3. Comprehensive evaluation of genetic and acquired thrombophilia markers for an individualized prediction of clinical thrombosis in patients with lymphoma and multiple myeloma;Journal of Thrombosis and Thrombolysis;2024-04-27

4. Thrombosis risk prediction in lymphoma patients: A multi‐institutional, retrospective model development and validation study;American Journal of Hematology;2024-04-23

5. Developing a risk assessment tool for cancer-related venous thrombosis in China: a modified Delphi-analytic hierarchy process study;BMC Cancer;2024-01-23